AI Tool Comparison
Comparing as AI Academic & Research Search EnginesOpenEvidence vs Consensus AI
Compare features, pricing, pros & cons, and user ratings to decide which AI tool is best for your needs.
OpenEvidence
VS
Consensus AI
Verdict by Category
Detailed category analysis is not available for this comparison.
Detailed Comparison
Feature
OpenEvidence
Consensus AI
Pricing
FreemiumOpenEvidence is free for all verified US healthcare professionals. NPI verification is required to access the platform. The free tier includes full medical AI search, DeepConsult, Visits, Voice Mode, clinical calculators, and the AI-Integrated Doctor Dialer.
Enterprise pricing applies to health system deployments with EHR integration (Epic), multi-subspecialist AI agents, custom knowledge bases, priority compute, advanced visualization, and API licensing for clinical decision support integration into third-party platforms.
Contact OpenEvidence through openevidence.com for enterprise and health system pricing. Note: The platform withdrew from the EU and UK in April 2026 and is currently available to US healthcare professionals only.
FreemiumConsensus offers a free plan with limited searches per month, paper summaries, and Consensus Meter access — enough to evaluate the platform without a credit card.
The Premium plan runs approximately $9.99–$15/month (billed annually at lower rates) and unlocks unlimited searches, Deep Search literature reviews, Study Snapshots, saved history, citation exports, and faster AI synthesis.
A Pro/Teams plan is available for research groups and organizations at approximately $65/month per seat or higher, adding collaboration features, usage analytics, and API access. Student discounts are available with a verified academic email address. Pricing is subject to change — verify current rates at consensus.app.
Categories
AI Healthcare ToolsAI Research & Education ToolsAI Search Engines
AI Search EnginesAI Research & Education Tools
Summary
AI clinical decision support free for verified physicians — 757K+ doctors, $12B valuation, peer-reviewed answers
AI-powered academic search engine — find answers from 220M+ peer-reviewed papers with citations
OpenEvidence Pros & Cons
Pros
- Free for all verified US physicians — no cost barrier for individual clinician adoption
- 757,000+ verified physicians, 40%+ of US doctors use it daily — most widely adopted clinical AI in the US
- $12B valuation (January 2026), $250M Series D — Thrive Capital and DST Global backed
- Answers grounded exclusively in peer-reviewed literature — zero hallucination risk from non-medical sources
- 20M+ clinical consultations per month — proven real-world clinical usage at unprecedented scale
- Epic EHR integration live at Sutter Health — first public health system embedding of clinical AI in EHR
- DeepConsult AI agent handles multi-step clinical reasoning — goes beyond basic search to structured clinical analysis
Cons
- Withdrew from EU and UK in April 2026 — US-only availability limits international use
- Free tier requires verified NPI number — not accessible to non-US clinicians or students without credentials
- Impact on actual clinical decision-making scored only 1.95/4 in one study — physicians still cautious
- DeepConsult and enterprise features require institutional pricing
- Full chart-aware clinical support (reading patient records proactively) not yet available
- Only 20% of physicians fully support AI in clinical decision-making — adoption barriers remain
Consensus AI Pros & Cons
Pros
- 220M+ paper corpus — one of the broadest peer-reviewed academic search databases available
- Consensus Meter gives instant visual signal on scientific agreement — unique feature
- Zero hallucination risk — every answer anchored to peer-reviewed citations
- Scholar Agent on GPT-5 enables complex multi-step literature research agentic workflows
- 5M+ active users — most widely adopted AI academic search engine globally
- Free tier is genuinely useful, not artificially crippled
- Medical Mode adds safety layer for clinical and health research queries
Cons
- Coverage limited to academic literature — not useful for news, market research, or general web search
- Deep Search and Scholar Agent locked behind paid plans
- Database updates monthly — not real-time like web search tools
- Less useful for niche or very recent research not yet indexed in major academic databases
- No direct PDF full-text access — links out to source publications